Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Prevention of Mortality with Long-Term Administration of Human Albumin in Subjects with Decompensated Cirrhosis and Ascites

Prevention of Mortality with Long-Term Administration of Human Albumin in Subjects with Decompensated Cirrhosis and Ascites

99 years or below
All genders
Phase 3
This study is designed to evaluate the effects of Albutein 20% infusion on long-term survival (1-year transplant-free) in liver cirrhosis compared to the Standard Medical Treatment (SMT).
Learn More
Phenotype Genotype and Biomarkers (PGB) In ALS and Related Disorders

Phenotype Genotype and Biomarkers (PGB) In ALS and Related Disorders

99 years or below
All genders
Reliance Agreement Request
Learn More
A RANDOMIZED DOUBLE BLINDED CONTROLLED TRIAL OF A RAPID PLEURODESIS PROTOCOL AFTER INDWELLING PLEURAL CATHETER PLACEMENT FOR MALIGNANT PLEURAL EFFUSIONS (THE RAPID TRIAL)

A RANDOMIZED DOUBLE BLINDED CONTROLLED TRIAL OF A RAPID PLEURODESIS PROTOCOL AFTER INDWELLING PLEURAL CATHETER PLACEMENT FOR MALIGNANT PLEURAL EFFUSIONS (THE RAPID TRIAL)

99 years or below
All genders
Please see attached protocol, pages 7-9
Learn More
An extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension

An extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension

99 years or below
All genders
Phase 3
This is a Phase 3a, extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension. The purpose of this study is to provide or continue to provide bardoxolone methyl to eligible subjects who participated in the CATALYST study. The study will also collect ongoing safety …
Learn More
A Prospective Multicenter Non-Blinded Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects with an Acute Complicated Type B Aortic Dissection

A Prospective Multicenter Non-Blinded Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects with an Acute Complicated Type B Aortic Dissection

99 years or below
All genders
Phase 3
relying on the Chesapeake IRB
Learn More
EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR)

EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR)

99 years or below
All genders
This is a multicenter, non-blinded, prospective observational cohort study of 1000 patients enrolled in an AlloSure testing registry, including 300 patients at centers with planned renal surveillance biopsies at 12 months post-transplantation. The other 700 patients will be from centers that do not perform protocol surveillance biopsies. This registry study …
Learn More

Low-Dose Naltrexone to Improve Physical Health in Patients with Vasculitis (LoDoNaVasc)

18 years - 90 years
All genders
Phase 2
The purpose of this study is to see whether a drug called naltrexone improves health-related quality of life in patients with vasculitis. Naltrexone is a prescription drug approved for a different reason at a higher dose than the dose used in this study. However, “low dose naltrexone” is widely used, …
Learn More
UPCC 11417: A Phase 3 Multicenter Randomized Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia

UPCC 11417: A Phase 3 Multicenter Randomized Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia

99 years or below
All genders
Phase 3
Request for collaborative review: WIRB serving as IRB of record.
Learn More
Multicenter randomized double-blind parallel-group add-on superiority study to compare the efficacy and safety of ponesimod to placebo in subjects with active relapsing multiple sclerosis who are treated with dimethyl fumarate (Tecfidera )

Multicenter randomized double-blind parallel-group add-on superiority study to compare the efficacy and safety of ponesimod to placebo in subjects with active relapsing multiple sclerosis who are treated with dimethyl fumarate (Tecfidera )

99 years or below
All genders
Phase 3
This is a study to find out whether patients with active forms of Relapsing Multiple Sclerosis (RMS) who are treated with dimethyl fumarate (Tecfidera®) can be treated better by the addition of ponesimod (study drug). The purpose is also to evaluate the effect on disability and the safety of these …
Learn More
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED Trial)

Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED Trial)

99 years or below
All genders
This application is a request to execute a reliance agreement with the Cincinnati Children's Hospital Medical Center (CCHMC) IRB.
Learn More
171 - 180 of 1243